Baliforsen
- Generic Name
- Baliforsen
- Drug Type
- Biotech
- CAS Number
- 1698048-23-5
- Unique Ingredient Identifier
- DR9CF3915M
A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1
- First Posted Date
- 2014-12-09
- Last Posted Date
- 2022-12-06
- Lead Sponsor
- Ionis Pharmaceuticals, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT02312011
- Locations
- 🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸University of Florida, Gainesville, Florida, United States
🇺🇸Kennedy Krieger Institute, Baltimore, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath